par Polastro, Laura;Aftimos, Philippe ;Awada, Ahmad
Référence Expert review of anticancer therapy, 14, 6, page (649-665)
Publication Publié, 2014
Référence Expert review of anticancer therapy, 14, 6, page (649-665)
Publication Publié, 2014
Article révisé par les pairs
Titre: |
|
Auteur: | Polastro, Laura; Aftimos, Philippe; Awada, Ahmad |
Informations sur la publication: | Expert review of anticancer therapy, 14, 6, page (649-665) |
Statut de publication: | Publié, 2014 |
Sujet CREF: | Cancérologie |
Pharmacologie | |
Mots-clés: | breast cancer |
chemotherapy | |
eribulin | |
review | |
solid tumor | |
MeSH keywords: | Alopecia -- chemically induced |
Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Carcinoma -- drug therapy -- secondary | |
Chemotherapy, Adjuvant | |
Clinical Trials as Topic | |
Drug Approval | |
Drug Resistance, Neoplasm | |
Drugs, Investigational | |
Ethers, Cyclic -- pharmacology | |
Fatigue -- chemically induced | |
Female | |
Furans -- adverse effects -- chemistry -- pharmacology -- therapeutic use | |
Humans | |
Ketones -- adverse effects -- chemistry -- pharmacology -- therapeutic use | |
Macrolides -- pharmacology | |
Molecular Targeted Therapy | |
Multicenter Studies as Topic | |
Neoadjuvant Therapy | |
Neutropenia -- chemically induced | |
Peripheral Nervous System Diseases -- chemically induced | |
Tubulin Modulators -- adverse effects -- chemistry -- pharmacology -- therapeutic use | |
United States | |
United States Food and Drug Administration | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1473-7140 |
info:doi/10.1586/14737140.2014.920693 | |
info:scp/84901393389 | |
info:pmid/24852360 |